What is NDC 73606-010?

73606-010 is the product NDC for Empaveli (pegcetacoplan), Pegcetacoplan 1080 mg/20mL injection, solution, listed with the FDA by Apellis Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Apellis Pharmaceuticals, Inc., NDC labeler code 73606. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Empaveli?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Empaveli NDC 73606-010 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)73606-010Labeler and product segments. Claims need a package NDC.

Product NDC at billing width73606-0010Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
73606-010-01	73606001001	1 VIAL in 1 CARTON (73606-010-01) / 20 mL in 1 VIALMarketed from May 14, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Empaveli
Generic name (nonproprietary): pegcetacoplan
Active ingredients: Pegcetacoplan — 1080 mg/20mL
Dosage form: Injection, Solution
Route: Subcutaneous
Labeler: Apellis Pharmaceuticals, Inc.NDC labeler code 73606
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 215014
Marketing start: May 14, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Complement Inhibitors (Mechanism)
Identifiers: Product ID 73606-010_a2186f40-2a97-4599-a1a6-e479baa8c1d9SPL ID a2186f40-2a97-4599-a1a6-e479baa8c1d9SPL set ID c23d89e9-b00b-4520-e053-2995a90a95afRxCUI 2557386, 2557391UNII TO3JYR3BOU
Pharmacologic class: Complement Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N473606001001 followed by a unit qualifier and the quantity

Package 73606-0010-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 21, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

EMPAVELI is a complement inhibitor indicated: for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH). ( 1.1 ) for the treatment of adult and pediatric patients aged 12 years and older with C3 glomerulopathy (C3G) or primary immune-complex membranoproliferative glomerulonephritis (IC-MPGN), to reduce proteinuria and the loss of kidney function. ( 1.2 ) 1.1 Paroxysmal Nocturnal Hemoglobinuria EMPAVELI ® is indicated for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH). 1.2 C3 Glomerulopathy or Primary Immune-Complex Membranoproliferative Glomerulonephritis EMPAVELI ® is indicated for the treatment of adult and pediatric patients aged 12…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 73606-010

What is NDC 73606-010?: 73606-010 is the product NDC for Empaveli (pegcetacoplan), Pegcetacoplan 1080 mg/20mL injection, solution, listed with the FDA by Apellis Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Empaveli (Pegcetacoplan).
What is the active ingredient?: Pegcetacoplan.
Who is the labeler?: Apellis Pharmaceuticals, Inc., NDC labeler code 73606. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Empaveli?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Empaveli (Pegcetacoplan) NDC 73606-010